These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6965424)

  • 21. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
    Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
    Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 23. The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults.
    McCoy JL; Fefer A; Ting RC; Glynn JP
    Cancer Res; 1972 Aug; 32(8):1671-8. PubMed ID: 4339747
    [No Abstract]   [Full Text] [Related]  

  • 24. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis.
    Grönberg A; Kiessling R; Eriksson E; Hansson M
    J Immunol; 1981 Nov; 127(5):1734-9. PubMed ID: 6975295
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors.
    Mathieson BJ; Campbell PS; Potter M; Asofsky R
    J Exp Med; 1978 Apr; 147(4):1267-79. PubMed ID: 306411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin and theta-bearing murine leukemias and lymphomas.
    Shevach EM; Stobo JD; Green I
    J Immunol; 1972 May; 108(5):1146-51. PubMed ID: 4112916
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction of leukemia in BALB mice by allogeneic AKR leukemic cells.
    Pasqualini CD; Saal F; Braylan RC; Rabasa SL
    Int J Cancer; 1970 May; 5(3):338-45. PubMed ID: 5452067
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunobiology of a spontaneous murine B cell leukemia (BCL1).
    Strober S; Gronowicz ES; Knapp MR; Slavin S; Vitetta ES; Warnke RA; Kotzin B; Schröder J
    Immunol Rev; 1979; 48():169-95. PubMed ID: 121100
    [No Abstract]   [Full Text] [Related]  

  • 29. A new concept of immunoregulation and its application to leukemia and lymphoma.
    Schwartz RS
    Tumori; 1973; 59(5):383-6. PubMed ID: 4149958
    [No Abstract]   [Full Text] [Related]  

  • 30. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular immune response to a drug-treated L5178Y lymphoma subline.
    Nicolin A; Bini A; Coronetti E; Goldin A
    Nature; 1974 Oct; 251(5476):654-5. PubMed ID: 4138894
    [No Abstract]   [Full Text] [Related]  

  • 32. Secondary induction of cytotoxic T lymphocytes with solubilized syngeneic tumor cell plasma membranes.
    Alaba O; Law LW
    J Exp Med; 1978 Nov; 148(5):1435-9. PubMed ID: 309916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 34. A new model for leukemia-lymphoma metastasis: differential growth and rejection of murine lymphoid-leukemia cell lines in the bone marrow.
    Kamenov B; Kieran MW; Leigh JB; Greenberg AH; Longenecker BM
    Symp Fundam Cancer Res; 1983; 36():245-64. PubMed ID: 6679093
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of transformation of murine thymocytes by thymic epithelium.
    Peled A; Haran-Ghera N
    Nature; 1978 Jul; 274(5668):266-9. PubMed ID: 308185
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
    Finklestein JZ; Byfield J; Tittle K; Imagawa DT
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
    [No Abstract]   [Full Text] [Related]  

  • 37. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
    Sharma JM; Herberman RB; Djeu JY; Nunn ME
    J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced AKR leukemogenesis by the dual tropic viruses. II. Effect on cell-mediated immune responses.
    Peled A; Hoffman AD; Levy JA; Haran-Ghera N
    Leukemia; 1987 May; 1(5):450-6. PubMed ID: 2823021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on column fractionation of immune cells. 3. Tumor neutralization test].
    Eckert R; Pasternak G
    Acta Biol Med Ger; 1973; 31(2):305-10. PubMed ID: 4544039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.